Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Inmune Bio (INMB) Receivables Refunds (2017 - 2023)

Inmune Bio's Receivables Refunds history spans 7 years, with the latest figure at $176000.0 for Q3 2023.

  • For Q3 2023, Receivables Refunds rose 54.39% year-over-year to $176000.0; the TTM value through Sep 2023 reached $176000.0, up 54.39%, while the annual FY2022 figure was $362000.0, 38.75% down from the prior year.
  • Receivables Refunds for Q3 2023 was $176000.0 at Inmune Bio, up from $112000.0 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $591000.0 in Q4 2021 and bottomed at $51000.0 in Q2 2021.
  • The 5-year median for Receivables Refunds is $148828.5 (2020), against an average of $201997.6.
  • The largest YoY upside for Receivables Refunds was 423.01% in 2021 against a maximum downside of 67.1% in 2021.
  • A 5-year view of Receivables Refunds shows it stood at $105842.0 in 2019, then increased by 6.76% to $113000.0 in 2020, then surged by 423.01% to $591000.0 in 2021, then crashed by 38.75% to $362000.0 in 2022, then plummeted by 51.38% to $176000.0 in 2023.
  • Per Business Quant, the three most recent readings for INMB's Receivables Refunds are $176000.0 (Q3 2023), $112000.0 (Q2 2023), and $396000.0 (Q1 2023).